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Abstract 
The effect of congeners of nitrogen monoxide (NO) on iron (Fe) uptake from 59Fe-125I-transferrin (Tf) and release of 59Fe from 
prelabelled cells have been investigated in SK-MEL-28 human melanoma cells, human K562 cells and mouse MDW-4 cells. These 
studies have been initiated as it has been suggested that the tumoricidal effects of NO may be mediated by its acting to release Fe from 
cells (Hibbs et al., 1984 Biochem. Biophys. Res. Commun. 123, 716-723; Hibbs et al., 1988 Biochem. Biophys. Res. Commun. 157, 
87-94). The nitrosonium ion (NO +) generator, sodium nitroprusside (SNP), decreased 59Fe uptake by melanoma cells to 57% of the 
control without decreasing 125I-Tf uptake after a 4-h incubation with 59Fe-125-Tf (1.25 /xM). Longer incubations up to 24 h decreased 
59Fe uptake and also 125I-Tf uptake. Two breakdown products of SNP, ferricyanide and cyanide, had no effect on 59Fe uptake. In 
addition, photolysis of the SNP solution prevented the inhibition of 59Fe uptake, suggesting that NO was the active agent. Two nitric 
oxide (NO.)  producing agents, 3-morpholinosydnonimine (SIN), and S-nitroso-N-acetylpenicillamine (SNAP), also decreased 59Fe 
uptake from 59Fe-tzsI-Tf. Superoxide dismutase increased the efficacy of SIN, and the NO-scavenger, oxyhaemoglobin, prevented the 
inhibition of 59Fe uptake mediated by SNAP, again suggesting that NO was the active agent. Furthermore, dialysis tudies demonstrated 
that none of the NO-generating agents could remove 59Fe from 59Fe-125I-Tf, suggesting that the decrease in cellular Fe uptake observed 
was not due to NO releasing Fe from the Fe-binding sites of Tf. Despite the ability of NO-producing agents at inhibiting 59Fe uptake by 
cells, they could not remove significant amounts of 59Fe from melanoma cells prelabelled with either 59Fe-citrate or59Fe-125I-Tf. Similar 
data were obtained using K562 and MDW-4 cells. Interestingly, the NO + generating agent, SNP, had no effect on [3H]thymidine uptake. 
However, when SNP was converted to an NO • generator by the addition of 1 mM ascorbate, its effect was similar to the NO • generator, 
SNAP, markedly reducing [3H]thymidine incorporation to 33% of the control value. The addition of unlabelled iferric Tf (0.625/xM) to 
SNAP ameliorated its inhibitory effect on cellular [3H]thymidine uptake, suggesting that the interaction of NO. with Fe was of 
importance in the inhibition observed. The results are discussed in the context of the cytostatic potential of NO via its binding to Fe. 
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1. Introduction 
Abbreviations: AM, activated macrophage; BSS, balanced salt solu- 
tion; cGMP, guanosine 3', 5'-cyclic monophosphate; Hb, haemoglobin; 
MEM, Eagle's modified minimum essential medium; NAP, N-acetyl-D- 
penicillamine; NO, nitrogen monoxide; NO., nitric oxide; NO +, nitroso- 
nium ion; SOD, superoxide dismutase; SIN, 3-morpholinosydnonimine; 
SNP, sodium nitroprusside; SNAP, S-nitroso-N-acetylpenicillamine; Tf, 
transferrin 
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Nitrogen monoxide (NO) is produced in a wide variety 
of mammalian cells where it has a physiological role as a 
short-lived messenger molecule [1]. Recently, congeners of 
NO have been implicated to play important roles in a wide 
range of biological processes, including neurotransmission, 
inhibition of platelet aggregation, smooth muscle relax- 
ation, immune regulation, iron metabolism and cytotoxic- 
ity [1-4]. 
Many of the biological effects of NO are mediated 
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through its avid binding to Fe centres, resulting in a variety 
of metabolic hanges, including mobilisation of Fe from 
ferritin [5], modulation of protein activity [4,6-8], and 
intracellular Fe release [911. With regard to the role of NO 
in Fe release from cells, Hibbs and others have shown that 
activated macrophages (AM) produce reactive nitrogen 
intermediates, including NO [10-13]. Co-cultivation of 
AM with tumor target cells results in the inhibition of 
target cell DNA synthesis and mitochondrial respiration, 
and in addition, a concomitant loss of a large fraction 
(64%/24 h) of intracellular Fe [9]. Considering their re- 
suits, Hibbs and associates [9] then speculated that the 
inhibition of DNA synthesis and mitochondrial respiration 
may be related to the loss of Fe, since the functional 
integrity of these metabolic pathways are dependent upon 
the activities of proteins containing Fe centres. Additional 
studies by this group of workers demonstrated that mito- 
chondrial aconitase (an Fe-S protein) is inhibited in NO- 
generating cells [14], and that this inhibition occurred 
simultaneously with the inhibition of DNA synthesis. 
Moreover, it was suggested that the efflux of Fe from cells 
observed in previous tudies was due to the release of Fe 
from aconitase [14]. Further support for the role of an 
interaction between NO and Fe in AM-induced cytostasis 
have come from recent investigations demonstrating stable 
Fe-nitrosyl complexes in AM [15,16] and their target cells 
[17,18]. 
From these observations it was tempting to speculate 
that NO may be diffusing into cells, ligating to the Fe 
centres of proteins, removing Fe, and then diffusing from 
the cell in the form of Fe-nitrosyl complexes. Indeed, 
Vanin [19] has suggested that cells exposed to NO release 
Fe complexed to this molecule and also to thiol ligands 
such as cysteine. Furthermore, in contrast o the work of 
Hibbs and others [14-16], Vanin and associates [20] have 
suggested that the Fe released may be derived from 
'loosely-bound' pools of non-heme Fe (free Fe) instead of 
mitochondrial Fe-S centres. 
Considering the study ,of Hibbs and associates demon- 
strating Fe release from tumor target cells co-cultivated 
with AM [9], it is uncertain whether this Fe was derived 
from a physiologically relevant Fe pool, as these authors 
used a non-physiologically relevant Fe complex (59Fe- 
citrate) to label target cells. It is important o note that 
under physiological circumstances practically all Fe in the 
plasma is bound to transferrin (Tf), and cells obtain Fe via 
the binding of Tf to the Tf receptor (TfR). The Tf-TfR 
complex is then internalised by endocytosis and the Fe 
released from Tf by a process involving endosomal cidifi- 
cation [21,22]. 
The present study was designed to investigate whether 
congeners of NO could act as Fe chelators to remove 59Fe 
from cells prelabelled using 59Fe-125I-Tf. Furthermore, as 
Fe is essential for cell growth and proliferation [23], the 
effect of NO congeners on 59Fe uptake from 59Fe-125I-Tf 
was also considered important to examine, as inhibition of 
Fe uptake by tumor target cells could also lead to a state of 
Fe deprivation and hence, cytostasis. 
2. Materials and methods 
2.1. Chemicals 
Iron-59 chloride (as ferric chloride in 0.1 M HCI) and 
iodine-125 (as sodium iodide) were purchased from 
Dupont, NEN products, Boston, MA. Pronase and human 
transferrin were purchased from Boehringer-Mannheim. 
Eagle's modified minimum essential medium (MEM), 
Hanks' balanced salt solution and penicillin-streptomycin 
were obtained from Gibco Laboratories. N-2-hydroxyeth- 
ylpiperazine-N'-2-ethanesulfonic acid (Hepes), 8-bromo- 
guanosine 3', 5'-cyclic monophosphate (8-bromo-cGMP), 
bovine liver catalase (EC 1.11.1.6) and bovine erythrocyte 
superoxide dismutase (EC 1.15.1.1) were obtained from 
Sigma Chemical Co., St. Louis, MO, USA. Non-essential 
amino acids (100 × concentrate), RPMI-1640 medium and 
fetal calf serum (FCS) were obtained from ICN Biomedi- 
cals, Costa Mesa, CA 92626. Fungizone (amphotericin B) 
was obtained from Squibb, Montreal, Canada. All other 
chemicals were of analytical reagent quality. 
2.2. Nitrogen monoxide-generating compounds 
As different redox forms of NO have different biologi- 
cal effects [3,24], both nitric oxide (NO.)  and nitrosonium 
ion (NO + ) generators were examined for their effects on 
Fe uptake and release. The NO- generating compounds 
used were: S-nitroso-N-acetylpenicillamine (SNAP) and 
3-morpholinosydnonimine (SIN) [24,25]. SNAP was syn- 
thesized from N-acetyl-D-penicillamine (NAP) according 
to the method of Field et al. [26]. SIN and its inactive 
analogue, SIN-1C, were kind gifts from Dr. Rainer Hen- 
ning (Cassella, Frankfurt, Germany). The NO + generator, 
sodium nitroprusside (SNP) [3,24], was obtained from 
Sigma. All chemicals were added to incubation medium 
immediately prior to an experiment and all solutions were 
prepared in containers wrapped in aluminium foil. This 
latter procedure was adopted to prevent undue photolysis 
of the compounds in solution [25]. 
In order to obtain products of SNP devoid of NO +, the 
photolysis of SNP was performed by a 7-day exposure of 
10 mM SNP to white fluorescent light, as described by 
Kiedrowski et al. [27]. 
2.3. Cells 
The human melanoma cell line, SK-MEL-28 (American 
Type Culture Collection, Rockville, MD; ATCC), and the 
human K562 erythroleukemia cell line (ATCC) were used 
in the present study as the Fe metabolism of these cell 
lines are well characterised [22,28-31]. The MDW4 cell 
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line was derived from a DBA-2 mouse leukemia nd was 
kindly provided by Dr. W. Lapp (McGill University, De- 
partment of Physiology, Montreal, Canada). This cell line 
was used because it has been recently shown to be sensi- 
tive to AM-mediated cytostasis (W. Lapp, personal com- 
munication). Human melanoma cells were grown and sub- 
cultured as described previously [28]. The K562 and 
MDW4 cell lines were grown in RPMI 1640 medium 
containing 10% FCS, as described [31]. 
2.4. Protein purification and labelling 
Human apoTf (Boehringer Mannheim) was prepared 
and labelled with 59Fe and 125I as described previously 
[281. 
Rabbit oxyhaemoglobin (Hb) was prepared from 30 ml 
of fresh blood from a New Zealand white rabbit. Briefly, 
cells were separated from the serum by centrifugation and 
then washed three times in phosphate-buffered saline (PBS, 
pH 7.4) by centrifugation at 2000 rpm/5 min. Approxi- 
mately 11 ml of packed cells was added to 9 ml of doubly 
distilled water, the solution mixed and then subjected to 
three rounds of freezing and thawing. Membranes were 
separated from the soluble supernatant by centrifugation at
12 000 rpm for 30 min at 4 ° C in a Sorvall RC-5B Super- 
speed Centrifuge. The supernatant containing oxyHb was 
removed and dialysed extensively against culture medium 
at 4 ° C and then sterilised by filtration. The Hb preparation 
was checked by spectrophotometry and found to be only in 
the oxy form. The concentration of oxyHb was determined 
using •541nm = 13.8 mM [32]. 
2.5. Iron metabolism - experimental procedure 
Iron and transferrin uptake 
The effect of NO-generating compounds on 59Fe and 
~25I-Tf uptake were investigated by incubating cells with 
59Fe-125I-Tf (1.25 /zM), 20 mM Hepes (pH 7.4) and the 
NO-generating compounds for up to 24 h at 37 ° C. After 
this incubation, the cells were washed 4 times with ice-cold 
BSS and then incubated with pronase (1 mg/ml)  for 30 
min at 4 ° C to separate membrane-bound (pronase-sensi- 
tive) from intemalised (pronase-resistant) radioactivity as 
described [28,33]. 
Iron and transferrin release 
The effect of NO-generating agents on 59 Fe release was 
examined by labelling cells with 59Fe-125I-Tf (1.25 /xM; 
Fe = 2.5 /xM) or 59Fe-citrate (molar ratio of Fe:citrate = 
1:100; [Fe] = 2.5 /zM) for 2-24 h at 37°C. After the cells 
were labelled, they were washed three times with pre- 
warmed medium and then incubated three times for 20 min 
at 37 ° C. This extensive washing procedure was imple- 
mented because, once released, the postulated NO-59Fe 
complex could then possibly be bound by ~25I-apoTf re- 
leased from cells. Hence, the 59Fe-Tf so formed could 
donate the released 59 Fe back to the cell resulting in no net 
59 Fe release. Considering this, it was important to remove 
Tf from the cells before the addition of NO-generating 
agents. A similar washing procedure was previously shown 
to completely deplete cells of Tf [29] and, in the present 
study, this method effectively removed ~25I-Tf as there was 
no ~25I-Tf remaining internalised in cells and none was 
released into the medium upon reincubation. Washed cells 
were then reincubated for 2-24 h at 37°C in MEM or 
MEM containing the NO-generating agents. After this 
time, the cells and supernatant were separated via centrif- 
ugation and the radioactivity was measured in each. 
Results were calculated as moles of Fe or Tf per gram 
of protein and as a percentage of the control and are 
expressed as the mean or mean _+ S.D. For melanoma 
cells, each determination was derived from 1 confluent 
petri dish containing approximately 5.106 cells, and this 
was equivalent to about 0.45 mg of protein via the bicin- 
choninic acid protein assay procedure [28]. For K562 and 
MDW-4 cells, each determination was derived from a tube 
containing 2-3 • 10  6 cells. Data were compared using the 
Student t-test and the results were considered statistically 
significant when P < 0.05. 
2.6. Dialysis studies 
Dialysis experiments were performed as described pre- 
viously [34] to determine the extent of direct chelation by 
NO of Tf-bound 59Fe. Briefly, culture medium containing 
59Fe-~25I-Tf (1.25 /~M) was incubated with the NO-gener- 
ating agent (1 raM) for 4 h at 37°C. A 4-h incubation 
period was used because, after this time, NO-generating 
agents were shown to be effective at reducing 59Fe uptake 
from 59Fe-125I-Tf (see Section 3.1 and Fig. 1). After this 
incubation, 1 ml aliquots were taken and dialysed in sacs 
against PBS (pH 7.4) with or without apoTf (1.25 /zM) for 
24 h at 4 ° C. ApoTf was added to the dialysate to act as a 
'sink' for 59 Fe released from the dialysis sac. Radioactivity 
was measured in the sacs and dialysate. Any leakage of 
59Fe-~25I-Tf rom the sacs could be detected from the 
distribution of 125I. 
2.7. [ 3 H]Thymidine incorporation 
The effect of NO-generating agents on [3H]thymidine 
uptake was performed after an 18-h exposure to these 
chemicals. The incorporation of [3H]thymidine was then 
assessed as described previously [35]. Cellular proliferation 
was also assessed by viable cell counts. 
2.8. Nitrite production in the presence of nitrogen monox- 
ide generators 
The accumulation of nitrite in cell culture supernatants 
is commonly used as a relative measure of NO production 
[4,10,36]. In the present study, NO-generating agents were 
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incubated in MEM for up to 18 h at 37 ° C and then nitrite 
was assayed using the Griess reagent which gives a charac- 
teristic spectral peak at 550 nm [37]. 
3. Results 
3.1. The effect of congeners of nitrogen monoxide on iron 
and transferrin uptake by tumor cells 
Effect of the nitrosonium ion (NO +) generator, sodium 
nitroprusside 
Considering the high avidity of NO for Fe [3], it was 
possible that this molecule could act as an Fe chelator to 
prevent Fe uptake from Tf, and hence, inhibit cellular 
proliferation. To explore this hypothesis, preliminary work 
in melanoma cells determined the effect of the NO + 
generator, SNP (1 mM), on 59Fe and 125I-Tf uptake from 
59Fe-leSI-Tf (1.25 /zM) as a function of incubation time. 
In these studies, SNP decreased internalised 59Fe uptake 
from 59Fe-]25I-Tf to 80% of the control value after only 5 
min of incubation (Fig. 1). Moreover, the extent of this 
inhibition increased as a function of incubation time, and 
after an incubation period of 4 h in the presence of SNP, 
internalised 59Fe uptake decreased to 57% of the control 
(Fig. 1). 
Further work examined the effect of SNP concentration 
on 59 Fe uptake from 59 Fe- ]25 I-Tf. Concentrations of SNP 
from 100 nM to 1 /zM were ineffective at preventing 59Fe 
uptake, whereas inhibition was evident at an SNP concen- 
tration of 0.05 mM, where 59Fe uptake was reduced to 
' ° °  . . . . . . .  [] 
80 ,! / /  co,,t, ol / 
i i  . 
O_ ~ i i i 
0 50 100 150 200 250 
Incubation Time (min} 
Fig. 1. The effect of the nitrosonium ion (NO + ) generator, sodium 
nitroprusside (SNP), on 59 Fe uptake from 59Fe- J25I-Tf by melanoma cells 
as a function of incubation time. The inset shows the internalised 59Fe 
uptake from 59Fe-1251-Tf in the presence and absence of SNP for the first 
15 min of the incubation. Cells were incubated with medium containing 
59 Fe- 125 I-Tf (1.25/zM) in the presence or absence of SNP (1 raM) for up 
to 4 h. After the required incubation period the cells were washed and 
then incubated with pronase (1 laag/ml) at 4 ° C for 30 min to separate 
intemalised from membrane-bound ra ioactivity. The results are means of 
duplicate determinations in a lypical experiment from a total of 3 
experiments performed. Variation between duplicates was less than 5%. 
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Fig. 2. The effect of sodium nitroprusside (SNP) concentration on 59Fe 
uptake from 59Fe-125I-Tf by melanoma cells. Cells were incubated with 
medium containing 59 Fe-125 I-Tf (1.25 gM) and various concentrations of 
SNP (0.05-5 mM) for 4 h at 37 ° C. After this incubation period the cells 
were washed and incubated with pronase (1 mg/ml)  for 30 min at 4 ° C to 
separate internalised from membrane-bound ra ioactivity. The results are 
means of duplicate and triplicate determinations in a typical experiment 
from a total of three experiments performed. For each experimental point 
the standard eviation did not exceed 5%. 
71% of the control value (Fig. 2). Increasing the concentra- 
tion of SNP from 1 mM to 5 mM, decreased 59Fe uptake 
from 58% to 43% of the control. In contrast to the 
decrease in 59Fe uptake, there was no decrease in the 
uptake of 125I-Tf by melanoma cells in the presence of 
SNP (0.05-5 mM; Fig. 2), suggesting that the decrease in 
59Fe uptake was not due some inhibitory effect on Tf 
uptake. Moreover, after a 4-h incubation with SNP (0.05-5 
mM), there was no cytotoxic effect observed, as judged by 
Trypan blue staining, cell adherence and LDH release. 
Furthermore, dialysis studies demonstrated that after a 4-h 
incubation of 59 Fe-125 I-Tf (0.1 mg/ml) with 1 mM SNP at 
37 ° C, there was no release of 59Fe into the dialysate, 
suggesting that NO does not remove 59Fe from 59Fe-125I- 
Tf. 
It is prudent o note that the decomposition of SNP 
(Na2[Fe(CN)sNO].2H20) in solution leads to the produc- 
tion of NO +, ferricyanide and cyanide (CN-) [3,24,38]. 
However, the addition of ferricyanide (1 mM) or CN- 
(1-5 mM) had no effect on 59Fe uptake from 59Fe-125I-Tf. 
Previous studies have demonstrated that SNP undergoes 
photolysis in solution resulting in the liberation of NO 
[38]. Moreover, prolonged exposure of SNP to light results 
in a solution devoid of NO [27], and in the present study, 
this procedure totally prevented the effect of SNP on 
inhibiting 59Fe uptake. Collectively, these control experi- 
ments strongly suggested that NO was the active agent. 
Oxyhaemoglobin (oxyHb) has been widely used to 
scavenge NO [1,3], and was used in the present study to 
examine if it could prevent the inhibitory effect of SNP on 
59Fe uptake. After a 4-h incubation, rabbit oxyHb (250 
/zM) did not prevent the effect of 1 mM SNP on inhibiting 
59Fe uptake. However, spectroscopic analysis revealed that 
for most of the incubation (up to 3 h) Hb remained in its 
oxy form with little being converted to cyanmetHb. Con- 
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Table 1 
The effect of the nitric oxide (NO.) generator, 3-morpholinosydnonimine 
(SIN), and the nitrosonium ion (NO + ) generator, sodium nitroprusside 
(SNP), on 59Fe and t25I-Tf uptake from 59Fe-125I-Tf (1.25 /.LM) by 
melanoma cells over a 24-h incubation 
% Control 
Intern. Fe Memb. Fe Intern. Tf Memb. Tf 
Control 100+6 100+8 100+5 100+3 
SIN (5 mM) 59+3 61+2 81+4 59+12 
SNP(1 mM) 45+1 115+2 66+3 51+4 
Result are mean + S.D. (3 determinations) from a typical experiment of 2 
experiments performed. 
sidering these data, it is known that the reaction between 
SNP and oxyHb is complex, with oxyHb being able to 
both stimulate the release of NO from SNP and also to 
bind NO via reaction with its heme centres [39-41]. Thus, 
since Hb remained in its oxy state for most of the incuba- 
tion period, it can be suggested that under the experimental 
conditions used, oxyHb may have stimulated the release of 
NO from SNP rather than scavenging it. 
Effect of nitric oxide (NO.) generators on iron uptake 
The effect of the two nitric oxide (NO.)  generators, 
SIN [24] and SNAP [25], were also examined for their 
effect on 59Fe uptake from 59Fe-lZSI-Tf. Incubation of 
melanoma cells with SNAP (1 mM) for 4 h reduced 59Fe 
uptake from 59Fe-125I-Tf to a similar extent as SNP (1 
mM), viz to 68% of the control value (Fig. 3). Increasing 
the concentration of SNAP to 2 mM only slightly in- 
creased its inhibitory effects on 59Fe uptake, viz Fe uptake 
was reduced to 63% of the control. In contrast, he precur- 
sor of SNAP, N-acetylpenicillamine (NAP), which does 
not contain the S-NO group, had no significant inhibitory 
effect on 59Fe uptake (Fig. 3). In contrast o the results 
obtained with SNP, addition of oxyHb (250 /zM) to the 
SNAP solution almost completely prevented the inhibition 
of 59Fe uptake seen in the presence of SNAP alone (Fig. 
3). Spectroscopic investigation of the Hb after the incuba- 
tion with SNAP revealed that some of the oxyHb had been 
converted to metHb. Hence, in this case, oxyHb did act as 
an scavenger for NO • released from SNAP. 
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Fig. 3. The effect of the nitric oxide (NO.) generators, S-nitroso-N- 
acetylpenicillamine (SNAP) and 3-morpholinosydnonimine (SIN) on 59 Fe 
uptake from 59 Fe-125I-Tf by melanoma cells. Cells were incubated for 4 
h with medium containing 59Fe-lZSI-Tf (1.25 /zM) in the presence of 
either SNP (1 mM), SNAP (1 mM), NAP (1 mM), SNAP (1 raM)+ 
haemoglobin (Hb; 250 /xM), Hb (250 /xM), SIN (5 mM) or SIN (5 
mM)+superoxide dismutase (SOD; 2500 U/ml).  After this incubation 
period the cells were washed and incubated with pronase (1 mg/ml)  for 
30 min at 4 ° C to separate internalised from membrane-bound ra ioactiv- 
ity. The results are means of duplicate or triplicate determinations in a 
typical experiment from two experiments performed. For each experimen- 
tal condition the standard eviation did not exceed 5%. 
The NO. generating agent, SIN, was far less effective 
than either SNP or SNAP, and at a concentration f 1 mM, 
had no significant effect on 59Fe uptake from 59Fe-125I-Tf. 
This may be because SIN produces both NO. and super- 
oxide (0 2 • -), which react together to produce peroxyni- 
trite [24,42]. Hence, this reaction probably effectively 
quenches much of the NO. produced. However, at a 
concentration of 5 mM, SIN reduced 59Fe uptake from 
59Fe-125I-Tf to 78% of the control value. Addition of 
superoxide dismutase (2500 U/ml)  to the SIN solution 
further educed 59Fe uptake to 59% of the control (Fig. 3), 
whereas SOD alone had no effect on 59Fe uptake. Further- 
more, SIN-1C, a SIN analogue without the N-NO group, 
had no inhibitory effect on 59Fe uptake. In contrast to 59Fe 
uptake, neither SNAP nor SIN reduced the uptake of 
Table 2 
The Effect of 8-bromo-guanosine-3',5'-cyclic monophosphate (8-Br-cGMP) on iron uptake from transferrin by melanoma cells 
Internalised iron uptake (nmol Fe/gPR) 
2 h Preincubation 
2 h Label 59Fe-Tf 
24 h Preincubation 
2 h Label 59Fe-Tf 
Control 48 + 1 45 + 6 
(100) ~ (100) 
10mM 45+3 41+1 
8-Br-cGMP (94) (91 ) 
Cells were preincubated for 2 or 24 h with either MEM (control) or MEM containing 10 mM cGMP and then 59Fe-transferrin (Tf) (1.25 /zM) was added 
and the incubation continued for a further 2 h. 
Results are mean + S.D. (4 determinations) from a typical experiment of two experiments performed. 
a Results in parentheses are expressed as a percentage of the control. 
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125I-Tf (data not shown). Moreover, as found for SNP, 
dialysis studies demonstrated that neither SNAP nor SIN 
could release significant anaounts of 59 Fe from 59 Fe-125 I-Tf. 
In contrast to the effects of NO-producing agents over a 
short-term incubation, after a 24-h incubation in the pres- 
ence of 59Fe-125I-Tf, SIN and SNP decreased both inter- 
nalised 59 Fe uptake and al:~o internalised and membrane Tf 
uptake by melanoma cells (Table 1). 
The effect of NO-generating agents on 59Fe uptake 
from 59Fe-125I-Tf were also examined in K562 cells and 
MDW-4 cells, and the results obtained were very similar to 
those reported for melanoma cells described above. 
Many of the effects of NO are mediated via activation 
of guanylate cyclase and the subsequent increase in guano- 
sine-3', 5'-cyclic monophosphate (cGMP) levels, and in 
many cell types the effects of NO can be mimicked by the 
membrane permeable cGMP analogue, 8-bromo-cGMP 
[1,43,44]. Hence, it was deemed worthwhile to investigate 
whether an elevation in the level of cGMP was responsible 
for the decrease in Fe uptake observed after incubation 
with NO-generating agents. To examine this, melanoma 
cells were preincubated for 2 or 24 h with 8-bromo-cGMP 
(10 raM), and then 59Fe-Tf (1.25 /xM) was added to the 
medium and the incubation continued for 2 h (see Table 
2). These studies demonstrated that incubation of cells 
with 8-bromo-cGMP had no appreciable ffect on 59Fe 
uptake from Tf, suggesting that elevated cGMP was not 
responsible for the decrease in Fe uptake observed. 
3.2. Effect of congeners of nitrogen monoxide on iron 
release 
The possible role of congeners of NO on mediating Fe 
release from target cells [9,19] was examined by prela- 
belling melanoma cells with either 59 Fe- 125 I-Tf (1.25 tzM; 
[Fe] = 2.5 /xM) or 59Fe-citrate (molar ratio of Fe:citrate = 
1:100; [Fe] = 2.5 /zM). 
After a 2-h labelling period with 59Fe-125I-Tf (1.25 
/xM) followed by extensive washing and reincubation i  
medium for 4 h, control cells released approximately 9% 
of their total cellular 59Fe (Table 3). When the NO + 
generator, SNP (1 mM), or the NO- generator, SIN (5 
mM), were added to the reincubation medium, 59Fe release 
increased to 11% and 13% of the control value, respec- 
tively (Table 3). A longer labelling period of 24 h with 
59Fe-1ZSI-Tf, ollowed by a reincubation period of 24 h in 
the presence of NO-producing agents, also resulted in little 
release of 59 Fe from melanoma cells (Table 3). 
In contrast to the results obtained using 59Fe-125I-Tf to 
label cells, if the cells were labelled using the non-physio- 
logically relevant Fe donor, 59Fe-citrate for 2 h, and then 
reincubated for 4 h in MEM or MEM containing 1 mM 
SNP, it is interesting to note that 60% and 47% of total 
cellular 59Fe was released, respectively (Table 3). Hence, 
compared to control cells labelled with 59Fe-125I-Tf, there 
has been over a 6-fold increase in the amount of 59Fe 
released into the medium. Melanoma cells were also incu- 
bated with 59Fe-citrate for 24 h and then reincubated for 
24 h in the presence and absence of NO-generating agents. 
In these experiments, 59Fe release from control cells was 
equal to 5%, and after treatment with SNP (1 mM) or 
SIN-1 (5 mM), 59Fe release increased to 10% and 17%, 
respectively (Table 3). Thus, after a 24-h incubation of 
melanoma cells with 59Fe-citrate, far less 59Fe is released 
than after a 2-h incubation with this complex. Neverthe- 
less, 59Fe-citrate is a non-physiological Fe donor which 
may not label the same intracellular Fe pools as 59Fe-Tf, 
and consequently, the results must be interpreted with care. 
Studies also examined the release of 59 Fe from human 
K562 cells prelabelled with 59Fe-125I-Tf for 2 h, and then 
reincubated in the presence of NO-producing agents for 18 
h. These experiments demonstrated that approximately 19% 
of total cell 59 Fe was released from the cells in the absence 
of NO-producing agents (Fig. 4). As found for melanoma 
cells labelled with 59 Fe-Tf, neither SNP nor SIN increased 
the release of 59Fe. The addition of ascorbate to SNP 
results in the reduction of NO + to NO • [24,45,46]. How- 
ever, this treatment did not stimulate 59Fe release from 
K562 cells (Fig. 4), even though it substantially reduced 
[3H]thymidine incorporation to a level comparable to that 
seen with the NO. generator, SNAP (see Section 3.3 and 
Fig. 5). Treatment of cells with SNAP slightly increased 
Table 3 
The effect of the nitrosonium ion (NO +) generator, sodium nitroprusside (SNP), and the nitric oxide (NO. )  generator, 3-morpholinosydnonimine (SIN), 
on the release of 59Fe from melanoma cells prelabelled with 59Fe-125I-Tf (1.25 /xM; [Fe] = 2.5 /zM) or 59Fe-citrate (molar ratio Fe: citrate = 1:100; 
[Fe] = 2.5 /xM) for 2 or 24 h followed by reincubation periods of 4 or 24 h, respectively 
% Iron-59 released 
2 h labe3t 59Fe125I-Tf 2 h label 59Fe-citrate 24 h label 59Fe125I-Tf 24 h label 59Fe-citrate 
4 h reincubation 4 h reincubation 24 h reincubation 24 h incubation 
Con 9+ 1 60-t- 1 8+ 1 5 + 1 
SNP(1 mM) 11 + 1 475:2 135:1 105:1 
SIN (5 mM) 135:1 _ 135:1 175:1 
Results are mean 5: S.D. (3 determinations) from a typical experiment of 3 experiments performed. 
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Fig. 4. The effect of the nitrosonium ion (NO + ) generator, sodium 
nitroprusside (SNP), and the nitric oxide (NO-) generators, 3-morpho- 
linosydnonimine (SIN) and S-nitroso-N-acetylpenicillamine (SNAP), on 
the release of 59Fe from prelabelled K562 cells. Cells were labelled for 2 
h at 37°C with $9Fe-I~$I-Tf (1.25 tiM), washed extensively to remove 
transferrin (see Section 2 for details) and then reincubated for 18 h at 
37°C in the presence of either SIN (0.5 mM), SNP (1 mM), SNP (1 
mM)+ascorbate (1 mM), ascorbate (1 mM), SNAP (1 mM) or N-acetyl- 
D-penicillamine (NAP; 1 mM). The results are means of triplicate deter- 
minations in a typical experiment from two experiments performed. For 
each experimental condition the standard eviation did not exceed 5%, 
1.25 /~M) to the SNAP solution substantially prevented its 
effect (Fig. 5). On the other hand, the addition of ferric 
citrate (molar ratio of Fe:citrate = 1 : 100) at a much higher 
Fe concentration ([Fe] = 50 #zM) was far less effective at 
preventing the inhibitory effect of SNAP on [3H]thymidine 
incorporation (Fig. 5). The addition of catalase (150 U/ml)  
and SOD (150 U/ml) to SNAP (1 mM) slightly increased 
its inhibitory effect on [3H]thymidine uptake, suggesting 
that for this compound, the generation of cytotoxic perox- 
ynitrite was not involved in the inhibition of [3H]thymi- 
dine incorporation. 
SIN (1 mM) also effectively reduced [3H]thymidine 
incorporation to 29% of the control (data not shown), 
although its effect was probably partly due to the cytotoxi- 
city of generated peroxynitrite, as there was a significant 
decrease in cell number and cellular viability. SOD (150 
U/ml) and catalase (150 U/ml) added to SIN (1 mM) 
partially prevented its inhibitory effect on [3H]thymidine 
incorporation, and under these conditions [3H]thymidine 
uptake was equal to 58% of the control. Interestingly, the 
addition of unlabelled Tf (0.625 /xM) to SIN, did not 
diminish its effect on [3H]thymidine incorporation, again 
suggesting that the effect of this compound was different 
to that induced by SNAP, and may be related to the 
generation of cytotoxic peroxynitrite by SIN [24,42]. 
The results described above for K562 cells were very 
the percentage of total 59Fe released to 30% (Fig. 4), 
whereas the inactive parent compound, NAP, had no ef- 
fect. Identical experiments in the MDW4 cell line gave 
similar results to those obtained using K562 cells (results 
not shown). 
3.3. [3H]Thymidine incorporation after exposure to nitro- 
gen monoxide-generating agents 
As NO generated by AM can inhibit ribonucleotide 
reductase of tumor target cells [47], it was of interest o 
examine the effects of the NO + and NO. generators on 
[3H]thymidine incorporation by K562 cells after an 18-h 
incubation with these agents. Interestingly, the NO + gen- 
erator, SNP (1 mM), had no effect on [3H]thymidine 
incorporation, whereas the addition of ascorbate (1 mM) to 
reduce NO + to NO. ,  resulted in a marked decrease in 
[3H]thymidine incorporation, viz to 33% of the control 
(Fig. 5). In contrast, ascorbate by itself had no significant 
effect on [3H]thymidine incorporation (Fig. 5). These ex- 
periments with ascorbate and SNP support he results of 
Lipton et al. [24], demonstrating that SNP is a nitroso 
compound with strong NO-- character [3], which requires 
the presence of reducing agents to convert it to an NO. 
generating compound. 
The NO- generator, SNAP, reduced [3H]thymidine in- 
corporation to 23% of the control value (Fig. 5). However, 
the addition of unlabelled iferric Tf (0.625 #xM; [Fe] = 
lOO - 7~ 
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Fig. 5. The effect of the nitrosonium ion (NO + ) generator, sodium 
nitroprusside (SNP), and the nitric oxide (NO.) generator, S-nitroso-N- 
acetylpenicillamine (SNAP), on the incorporation of [3H]thymidine by 
K562 cells. Cells were incubated for 18 h at 37°C in the presence of 
either SNP (1 mM), ascorbate (1 mM), SNP (1 mM)+ascorbate (1 mM), 
SNAP (1 raM), SNAP (1 mM)+Tf  (0.625 /zM), unlabelled iferric Tf 
(0.625 #xM), SNAP (1 mM)+50 #zM ferric citrate, or 50 #xM ferric 
citrate only. The cells were then washed and exposed to 10 #xCi/ml of 
[3H]thymidine for 1 h at 37 ° C. After this labelling period the cells were 
washed, incubated with 20% TCA for 1 h at 4 ° C, and then washed twice 
in ice-cold 10% TCA. The results are means of triplicate determinations 
in a typical experiment of two experiments performed. For each experi- 
mental condition the standard eviation did not exceed 5%. 
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Fig. 6. The effect of NO generating agents on nitrite formation in culture 
medium. The NO + generator, sodium nitroprusside (SNP; 1 mM), and 
the NO. generators, S-nitroso-N-acetylpenicillamine (SNAP; 1 mM) and 
3-morpholinosydnonimine (SIN; 1 and 5 mM), were incubated in culture 
medium at 37 ° C for 1-18 h. The inset shows the generation of nitrite 
from SNP over an incubation i?eriod of up to 18 h. After the required 
incubation the medium was then assayed for nitrite using the Griess 
reagent (see Section 2 for details). Results are means of duplicate 
measurements in a typical experiment of 2 experiments performed. The 
variation between replicates did not exceed 5%. 
similar to those obtained for MDW-4 cells in identical 
experiments (results not shown). 
3.4. The production of nitrite in the presence of nitrogen 
monoxide-generating a ents 
half-life due to its rapid conversion to peroxynitrite. It is 
also relevant to note that a SIN concentration f 5 mM was 
required to reduce 59Fe uptake from Tf, and even at this 
concentration the effect on Fe uptake was less than that 
seen with either SNP or SNAP (see Fig. 3). 
The NO • generator, SNAP (1 mM), produced far more 
nitrite than the NO + generator, SNP (1 mM; see Fig. 6), 
and from our nitrite measurements i  appeared that SNP 
was producing little NO. In contrast, in terms of inhibiting 
59Fe uptake from Tf, SNP (1 mM) was slightly more 
effective than SNAP (1 mM; see Fig. 3). It is also of 
importance to note that Feelisch and Noack [49] have 
demonstrated that SNP releases NO without he production 
of nitrite, and again, the apparent contradiction between 
nitrite levels and biological activity may be related to the 
different redox-related forms of NO generated by these 
compounds. Indeed, SNAP is a compound which contains 
NO bound to a S atom, and generates NO • [25] which can 
react with superoxide or oxygen to produce nitrite. In the 
case of SNP, this is a compound with strong NO ÷ charac- 
ter [3,24], which contains NO bound to Fe [38], and has 
been shown to transfer NO + equivalents to SH groups of 
proteins [24]. Hence, considering the different chemical 
properties of the redox-related species of NO generated by 
SNP and SNAP, and the probable different mechanism of 
NO release from these compounds [25], it is likely that the 
rate of formation of nitrite from each of these NO donors 
will differ substantially. In conclusion, the use of measur- 
ing an end-product such as nitrite to estimate biologically 
active NO levels must be tempered by knowledge of the 
redox-related chemistry of NO produced by different NO- 
generating compounds. 
Nitrite is one end-product of NO, and its accumulation 
is commonly used as are, lative measure of NO production 
[4,10,36]. In the present study the generation of nitrite in 
culture medium was very different for each of the NO 
donors tested (Fig. 6). After a 4-h incubation with SNP (1 
mM), SNAP (1 mM), SIN (1 mM) and SIN (5 mM), the 
amounts of nitrite present in the incubation media were 
equal to 4, 120, 500 and 1250 ~M, respectively. These 
results seemingly imply that SIN is producing far more 
NO than either SNAP or SNP. However, as described 
previously in Section 3.1, SIN was far less effective than 
either SNP or SNAP, and at a concentration f 1 mM, had 
no significant effect on 59Fe uptake from 59Fe-125I-Tf. The 
reason for this apparent discrepancy between the observed 
biological effect and nitrite formation probably lies in the 
fact that SIN generates both superoxide (0 2 • -)  and NO •, 
which rapidly react together to form peroxynitrite which 
then decomposes to produce nitrate [24,42,48]. Hence, in 
the case of SIN, the formation of nitrite is probably not a 
reliable indication of biological active NO • levels. In fact, 
the rapidity of nitrite formation (see Fig. 6) and the poor 
biological activity of SIN (in the absence of SOD) sug- 
gests that NO- generated by this compound has a short 
4. Discussion 
Activated macrophages are characterised by their capa- 
bility to mediate both cytostatic and cytotoxic effects on 
tumor target cells. Recent studies have suggested that these 
cells exert heir cytotoxic and cytostatic effects in part, via 
the generation of reactive nitrogen intermediates, including 
NO [50,51 ]. NO probably mediates its cytotoxic and cyto- 
static effects via its property of binding to Fe in the active 
centres of proteins which are essential for cellular growth 
and proliferation. These proteins include the rate-limiting 
enzyme of DNA synthesis, ribonucleotide reductase 
[47,52,53], NADH ubiquinone oxidoreductase and succi- 
nate-ubiquinone oxidoreductase of the electron transport 
chain [54], as well as aconitase of the citric acid cycle [14]. 
Furthermore, the inhibition of enzymic activity is report- 
edly accompanied by the loss of a large fraction (64%/24 
h) of intracellular Fe [9]. These observations suggest hat 
NO, through its high affinity for Fe [3,55], could act as an 
Fe chelator to bind and remove Fe from proteins with Fe 
centres, resulting in cytostasis. 
The present series of experiments were designed to 
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investigate the possible role of congeners of NO on pre- 
venting 59Fe uptake from 59Fe-125I-Tf, and also removing 
59Fe from prelabelled neoplastic ells. Moreover, the ef- 
fects of NO-generating agents on inhibiting [3H]thymidine 
incorporation and the role of Fe in this inhibition was also 
examined. It is prudent o note that NO has been shown to 
have different biological effects depending upon its redox 
state [24]. The reduced form of NO, nitric oxide (NO.) ,  
can modulate protein activity by direct coordination to Fe 
centres in proteins, whereas the oxidised form of NO, 
nitrosonium ion (NO+), can S-nitrosylate proteins via their 
thiol groups, a modification which may have important 
regulatory functions [3,24,56,57]. Considering this, the 
present studies were performed using both an NO + gener- 
ating agent and two NO. generating agents to examine 
their effects on Fe uptake and release. The NO-generating 
compounds were used in preference to AM, because these 
cells produce in addition to NO, a range of monokines 
[58], which could also perturb intracellular Fe metabolism 
[59] and possibly interfere with the interpretation of the 
results. 
Interestingly, both NO + and NO. generators ignifi- 
cantly decreased 59Fe uptake from 59Fe-~25I-Tf (Figs. 1-3). 
However, none of the agents were effective at removing 
substantial quantities of 59Fe from cells labelled with 
59Fe-Tf (Fig. 4; Table 3). This latter observation would 
seem to suggest hat neither edox form is acting as an Fe 
chelator to prevent he uptake of 59Fe after it has been 
released from 59Fe-~25I-Tf. Furthermore, despite the effect 
of NO-generators on decreasing Fe uptake, they had no 
effect on Tf uptake, suggesting that the decrease in Fe 
uptake observed was not due to a decrease in Tf uptake. It 
is important to note that the NO + generator, SNP, was just 
as effective as the NO. generator, SNAP, at preventing 
59Fe uptake. As described above, the chemistry of NO + 
dictates that it be involved in S-nitrosylation reactions, 
whereas NO. is predominately involved in reactions in- 
volved in the ligation to Fe [3]. Hence, if chelation was 
involved in preventing Fe uptake from Tf, the NO • gener- 
ating agents should be far more effective than the agent 
producing NO + . As both NO. and NO + generating agents 
were equally effective, and since neither could remove 
significant amounts of 59Fe from prelabelled cells, it is 
likely that these redox-related species of NO do not act as 
Fe chelators, and have some other effect on cellular Fe 
metabolism via mechanisms which may involve S-nitrosy- 
lation and/or ligation of NO- to Fe centres. 
Notwithstanding the above, one should still consider 
that NO may intercept Fe immediately after it has been 
released from Tf in the endosome, and then diffuse out of 
the cell as an Fe-nitrosyl complex. In addition, none of the 
NO-producing agents could remove 59 Fe from 59 Fe- 125 I-Tf, 
suggesting that the decrease in cellular Fe uptake observed 
was not due to NO releasing Fe from the Fe-binding sites 
of Tf. However, NO has been shown to ligate to the Fe 
atom within the Fe-binding site of lactoferrin [60], and 
since the Fe-binding site of serum Tf is very similar to that 
found in lactoferrin [61], it is possible that an NO-Fe-Tf 
charge-transfer complex may form. Moreover, since endo- 
somal acidification is involved in releasing Fe from Tf in 
melanoma cells [28,62] and K562 cells [22,31], the forma- 
tion of an NO-Fe-Tf complex may affect the lability of the 
Fe-binding site to acidification. Consequently, this may 
result in the decreased Fe uptake observed in the present 
investigation and further studies have been initiated to 
examine this hypothesis. 
As Fe is essential for both cellular growth and prolifera- 
tion [23], preventing Fe uptake from Tf may be one means 
of inhibiting tumor cell proliferation [35,63]. Indeed, since 
congeners of NO can decrease 59Fe uptake, it may be 
suggested that this effect could play a role in the cytostasis 
observed in tumor target cells after exposure to NO gener- 
ated by the AM. 
In contrast to short incubation periods with the NO-gen- 
erating agents, prolonged exposure of cells to SNP or SIN 
for 18-24 h resulted not only in a decrease in 59 Fe uptake, 
but also to a reduction in ~25I-Tf uptake. Recent studies 
have demonstrated that in contrast to NO • which increases 
activation of the Fe-responsive lement binding protein 
(IRE-BP) [4,7,8], NO + decreases activation of IRE-BP, 
which results in a decrease in TfR expression and Fe 
uptake [8]. These observations could explain the decrease 
in 59Fe and 125I-Tf uptake observed in the present study 
after a 24-h incubation with SNP (Table 1), but not the 
decrease in 59Fe uptake evident within 5 min of incuba- 
tion. In addition to the acute effects of NO at decreasing 
Fe uptake, the NO+-mediated down-regulation of the TfR 
and the resultant decrease in Fe uptake may also contribute 
to AM-induced tumor cell cytostasis. It should be noted 
that the effect of SIN (5 mM) on Fe and Tf uptake after 24 
h may be due to the production of cytotoxic peroxynitrite 
[24,42], as we observed a decrease in cellular viability. 
In the present investigation both short- and long-term 
incubations with 59 Fe-125I-Tf were used in order to attempt 
to label different intracellular Fe pools. Short incubations 
of 2 h would probably label the 'free' pool of Fe suggested 
to be the target of NO by Vanin [19], whereas longer 
incubations of 24 h would tend to label not only the 'free' 
pool of Fe, but also proteins with Fe centres, the latter of 
which Hibbs et al. [9] suggest o be the target of NO. In 
the present study, none of the NO-generating compounds 
were capable of removing significant amounts of 59Fe 
from cells under either of the labelling conditions used. In 
addition, it was also of interest hat labelling cells for 2 h 
with 59 Fe-Tf resulted in only 9% of total Fe being released 
upon reincubation with MEM alone (Table 3). In contrast, 
after labelling cells with 59 Fe-citrate for 2 h, 60% of total 
59Fe was released upon reincubation in MEM (Table 3). 
These results suggest that 59Fe-citrate may label non- 
physiologically relevant Fe pools, and it is prudent o note 
that Hibbs et al. [9] used 59Fe-citrate to label target cells to 
demonstrate the release of 59Fe after co-cultivation with 
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AM. Indeed, further studies are needed to determine 
whether AMs can release 59Fe from target cells labelled 
with the physiological Fe donor, diferric Tf. 
It is prudent o note that the NO + generator, SNP, had 
no effect on [3H]thymidme incorporation. However, the 
addition of ascorbate which reduces NO + to NO. 
[24,45,46] resulted in a marked decrease in [3H]thymidine 
incorporation to a level comparable to that observed with 
the NO. generator, SNAP (Fig. 5). Considering these 
results, it could be suggested that the redox-related species 
of NO (i.e., NO + produced by SNP [3,24] and NO. 
generated by SNAP [25]) have markedly different effects 
on DNA synthesis. Alternatively, in the absence of ascor- 
bate, the lack of any effect of SNP on [3H]thymidine 
incorporation may be due to the inefficient generation of 
NO, as reflected by the low levels of nitrite produced 
compared to either SIN or SNAP (see Fig. 6). However, 
this explanation is not entirely adequate, as SNP was more 
effective than both SNAP and SIN at reducing 59Fe uptake 
from Tf (Fig. 3), and our control experiments demon- 
strated that this effect was due to NO. As described in 
Section 3.4, it is important to note that the generation of 
nitrite by these agents may not reflect biologically active 
NO levels, and the mechanism of NO release from the 
compounds and the redox state of the NO generated must 
also be taken into account. 
It has been previously shown that the rate-limiting 
enzyme of DNA synthesis, ribonucleotide r ductase [52], 
requires both thiols and non-heme Fe in its reaction centre 
to maintain the key tyrosyl radical necessary for catalytic 
activity [64-66]. Hence, either NO + by reacting with thiol 
groups, or NO- by binding to Fe [3], could inhibit ribonu- 
cleotide reductase activity. It can be suggested that since 
the NO + generator, SNP, has no effect on [3H]thymidine 
incorporation, only NO. may inhibit the activity of the 
enzyme. However, to test this hypothesis more directly, 
further experiments need to be performed using isolated 
ribonucleotide r ductase and NO. and NO + generators. It 
is also of interest hat unlabelled iferric Tf could amelio- 
rate the inhibitory effect ef the NO • generator, SNAP, on 
[3H]thymidine incorporation (Fig. 5), suggesting that the 
interaction of NO. with Fe was of importance in the 
inhibition observed. In contrast, ferric citrate ([Fe] = 50 
/xM) was far less effective than unlabelled diferric Tf 
([Fe] = 1.25 /xM) at preventing the inhibition of 
[3H]thymidine incorporation observed in the presence of 
SNAP (Fig. 5), which may suggest hat ferric citrate may 
not be donating Fe to the appropriate Fe pool(s) involved 
in DNA synthesis. 
In conclusion, since NO. or NO + by themselves do not 
appear to efficiently release 59Fe from cells, it may be 
suggested that other factors such as monokines produced 
by the AM or the direct physical contact of the macrophage 
with the target cell may be required to facilitate Fe release. 
However, the decrease in Fe uptake seen after exposure to 
NO may suggest hat this effect could contribute to the 
cytostasis observed after the interaction of NO-producing 
AMs with target cells. 
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